4月9日 - ** WW国际WW.O股价盘前大涨21%至11.58美元
** 远程保健公司称将开始向符合条件的美国会员提供礼来LLY.N新批准的口服减肥药Foundayo
** Foundayo是一种每天服用一次的GLP-1类药物，它能帮助人们产生饱腹感，减少进食，从而避免每周注射一次。
** 该公司表示，将通过其 Med+ 计划提供服务，该计划包括临床医生护理、保险支持和治疗工具
** 表示自费会员的最低剂量价格为每月 149 美元起
** 补充说，在使用 GLP-1 药物的同时使用其行为支持服务的会员平均体重减轻幅度比未使用支持服务的会员高出近 30
** 截至上一交易日收盘，股价年累计下跌约 67
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.